Biomarker test for alzheimer disease

Access through your institution Buy or subscribe Shaw, L. M. _ et al_. Cerebrospinal fluid biomarker signature in Alzheimers disease neuroimaging initiative subjects. _Ann. Neurol._ 18,

403–413 (2009). > Aβ1–42 was identified as the most sensitive biomarker for AD, > with a detection rate of 96.4% This is a preview of subscription content, access via your institution

ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article *

Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn

about institutional subscriptions * Read our FAQs * Contact customer support Authors * Lisa Richards View author publications You can also search for this author inPubMed Google Scholar

RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Richards, L. Biomarker test for Alzheimer disease. _Nat Rev Neurol_ 5, 296 (2009).

https://doi.org/10.1038/nrneurol.2009.64 Download citation * Issue Date: June 2009 * DOI: https://doi.org/10.1038/nrneurol.2009.64 SHARE THIS ARTICLE Anyone you share the following link with

will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt

content-sharing initiative